← FDA DRUG APPROVALS

FDA NDA · NDA021388

TALC

Sponsor: SCIARRA LABS

APPLICATION
NDA021388
TYPE
NDA
ORIGINAL APPROVAL
2003-12-15
LATEST ACTION
2014-06-13
ROUTE
INTRAPLEURAL
DOSAGE FORM
POWDER
MARKETING STATUS
Prescription

Products

TALC · ReferencePrescription
TALC 5GM/BOT · POWDER · INTRAPLEURAL

Approval history

2014-06-13Labeling · Supplement 2 · standardLetterAP
2003-12-15Type 3 - New Dosage Form · Original · priorityLabelAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →